Metastasis-associated protein is a predictive biomarker for metastasis and recurrence in gastric cancer

  • Authors:
    • Yoshinaga Okugawa
    • Yasuhiko Mohri
    • Koji Tanaka
    • Mikio Kawamura
    • Susumu Saigusa
    • Yuji Toiyama
    • Masaki Ohi
    • Yasuhiro Inoue
    • Chikao Miki
    • Masato Kusunoki
  • View Affiliations

  • Published online on: August 25, 2016     https://doi.org/10.3892/or.2016.5054
  • Pages: 1893-1900
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The metastasis-associated (MTA) gene family is a critical component of the nucleosome remodeling and histone deacetylase complex, and plays an important role in metastatic processes. We systematically evaluated dysregulation of the MTA family to clarify their clinical significance in gastric cancer (GC). One hundred and forty-five patients who underwent surgery for GC were evaluated. We analyzed the expression levels of the MTA family (MTA1, 2 and 3) by qPCR in GC tissue, and the MTA1 protein expression in primary cancer and matched normal mucosa (NM) was measured using immunohistochemical analysis. The expression of all the MTA family members was significantly increased in a stage-dependent manner, and elevated expression of all of the MTA family members was correlated with metastatic factors and prognosis in GC patients. Multivariate analysis revealed that MTA1 overexpression was an independent risk factor for survival. Especially, elevated expression of MTA1 was significantly correlated with recurrence, and was an independent risk factor for lymph node metastasis. Immunohistochemical analysis demonstrated that MTA1 was predominantly expressed in the nuclei of primary GC cells but was not expressed in NM and in the cancer stroma. In conclusion, quantification of MTA expression may support the accurate diagnosis of disease staging and may help predict clinical outcomes.
View Figures
View References

Related Articles

Journal Cover

October-2016
Volume 36 Issue 4

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Okugawa Y, Mohri Y, Tanaka K, Kawamura M, Saigusa S, Toiyama Y, Ohi M, Inoue Y, Miki C, Kusunoki M, Kusunoki M, et al: Metastasis-associated protein is a predictive biomarker for metastasis and recurrence in gastric cancer. Oncol Rep 36: 1893-1900, 2016
APA
Okugawa, Y., Mohri, Y., Tanaka, K., Kawamura, M., Saigusa, S., Toiyama, Y. ... Kusunoki, M. (2016). Metastasis-associated protein is a predictive biomarker for metastasis and recurrence in gastric cancer. Oncology Reports, 36, 1893-1900. https://doi.org/10.3892/or.2016.5054
MLA
Okugawa, Y., Mohri, Y., Tanaka, K., Kawamura, M., Saigusa, S., Toiyama, Y., Ohi, M., Inoue, Y., Miki, C., Kusunoki, M."Metastasis-associated protein is a predictive biomarker for metastasis and recurrence in gastric cancer". Oncology Reports 36.4 (2016): 1893-1900.
Chicago
Okugawa, Y., Mohri, Y., Tanaka, K., Kawamura, M., Saigusa, S., Toiyama, Y., Ohi, M., Inoue, Y., Miki, C., Kusunoki, M."Metastasis-associated protein is a predictive biomarker for metastasis and recurrence in gastric cancer". Oncology Reports 36, no. 4 (2016): 1893-1900. https://doi.org/10.3892/or.2016.5054